← Dashboard
Nov 16, 2026 05:25 AM ET
Signal
FDA/Bio
Ideaya picks cancer drug candidate, targets human trial application in 2027
Ideaya selected a cancer drug candidate and targets a 2027 human trial application.
What changed
Ideaya selected a cancer drug candidate and targets a 2027 human trial application.
Why it matters
Ideaya selected a cancer drug candidate and targets a 2027 human trial application. — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
In reversal, American Cancer Society urges routine prostate cancer screening →
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →
PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →